| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.0M | -20.0% |
| Cost of Revenue | $5.9M | +103.6% |
| R&D Expense | $47.8M | +10.6% |
| SG&A Expense | $81.6M | +82.3% |
| Operating Income | -$121.3M | -65.3% |
| Income Tax | $0 | — |
| Net Income | -$130.4M | -66.1% |
| EPS (Basic) | -$1.66 | -37.2% |
| EPS (Diluted) | -$1.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.5M | +110.9% |
| Accounts Receivable | $2.7M | -33.0% |
| Inventory | $241K | — |
| Current Assets | $185.1M | +105.9% |
| Total Assets | $230.3M | +94.6% |
| Current Liabilities | $41.8M | +125.2% |
| Total Liabilities | $153.0M | +115.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.4M | -124.8% |
| Capital Expenditures | $4.9M | +283.6% |
| Investing Cash Flow | -$8.4M | +25.2% |
| Financing Cash Flow | $194.7M | +350.1% |
| Free Cash Flow | -$98.4M | -129.5% |
| -37.2% |
| Stockholders' Equity |
| $77.3M |
| +63.4% |